Gliclazide

Overview

Gliclazide (S1702) is a whole-cell beta-cell ATP-sensitive potassium currents blocker with an IC 50 of 184 nM. Gliclazide is used as an antidiabetic.

Application

Products | Products > Disease Areas > Alzheimer's Disease | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Neurodegenerative Disease | Products > Disease Areas > Cardiovascular Disease | Products > Disease Areas > Glucose Metabolism | Products > Signaling Pathways > Membrane Transporter/Ion Channel | Products > Research Areas > Cardiovascular Disease | Products > Signaling Pathways > Potassium Channel

Product Information

• Catalog No.: HY-B0753
• CAS No.: 21187-98-4
• Molecular Formula: C15H21N3O3S
• Molecular Weight: 323.41
• Purity: 99.58%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
• Solubility: ≥ 2.5 mg/mL (7.73 mM); Clear solution
• Availability: In-stock

Source

Original product source